China Reform Health Stock Last Dividend Paid

000503 Stock   10.09  0.13  1.31%   
China Reform Health fundamentals help investors to digest information that contributes to China Reform's financial success or failures. It also enables traders to predict the movement of China Stock. The fundamental analysis module provides a way to measure China Reform's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Reform stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

China Reform Health Company Last Dividend Paid Analysis

China Reform's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

 = 

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition

China Dividends Paid

Dividends Paid

8.2 Million

At present, China Reform's Dividends Paid is projected to decrease significantly based on the last few years of reporting.
Based on the recorded statements, China Reform Health has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).

China Last Dividend Paid Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Reform's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of China Reform could also be used in its relative valuation, which is a method of valuing China Reform by comparing valuation metrics of similar companies.
China Reform is currently under evaluation in last dividend paid category among its peers.

China Fundamentals

About China Reform Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze China Reform Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Reform using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Reform Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in China Stock

China Reform financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Reform security.